Publications 2016 [References 807–876]

807. Badahdah AM, Rashid H, Khatami A. Update on the use of meningococcal serogroup C CRM197-conjugate vaccine (Meningitec) against meningitis. Expert Review of Vaccines 2016;15:9-29. [Abstract] 

808. Newall AT, Reyes JF, McIntyre P, Menzies R, Beutels P, Wood JG. Retrospective economic evaluation of childhood 7-valent pneumococcal conjugate vaccination in Australia: uncertain herd impact on pneumonia critical. Vaccine 2016;34:320-7. [Abstract]

809. Britton PN, Dale RC, Nissen MD, Crawford N, Elliott E, Macartney K, Khandaker G, Booy R, Jones CA. Parechovirus encephalitis and neurodevelopmental outcomes. Pediatrics 2016;137:e20152848. [Abstract]

810. Dixit R, Herz J, Dalton R, Booy R. Benefits of using heterologous polyclonal antibodies and potential applications to new and undertreated infectious pathogens. Vaccine 2016;34:1152-61. [Abstract]

811. Smith MA, Liu B, McIntyre P, Menzies R, Dey A, Canfell K. Trends in genital warts by socioeconomic status after the introduction of the national HPV vaccination program in Australia: analysis of national hospital data. BMC Infectious Diseases 2016;16:52. [Full text]

812. Rashid H, Yin JK, Ward K, King C, Seale H, Booy R. Assessing interventions to improve influenza vaccine uptake among health care workers. Health Affairs (Project Hope) 2016;35:284-92. [Abstract]

813. Li-Kim-Moy J, Booy R. The manufacturing process should remain the focus for severe febrile reactions in children administered an Australian inactivated influenza vaccine during 2010. Influenza and Other Respiratory Viruses 2016;10:9-13. [Full text]

814. Clarke M, McIntyre PB, Blyth CC, Wood N, Octavia S, Sintchenko V, Giles L, Quinn H, Hill V, Hanly G, Lan R, Marshall HS. The relationship between Bordetella pertussis genotype and clinical severity in Australian children with pertussis. Journal of Infection 2016;72:171-8. [Abstract]

815. Hale S, Quinn HE, Kesson A, Wood NJ, McIntyre PB. Changing patterns of pertussis in a children's hospital in the polymerase chain reaction diagnostic era. Journal of Pediatrics 2016;170:161-5.e1. [Abstract]

816. Safarchi A, Octavia S, Wu SZ, Kaur S, Sintchenko V, Gilbert GL, Wood N, McIntyre P, Marshall H, Keil AD, Lan R. Genomic dissection of Australian Bordetella pertussis isolates from the 2008–2012 epidemic. Journal of Infection 2016;72:468-77. [Abstract]

817.    Banik GR, Alqahtani AS, Booy R, Rashid H. Risk factors for severity and mortality in patients with MERS-CoV: analysis of publicly available data from Saudi Arabia [letter]. Virologica Sinica 2016;31:81-4. [No abstract available]

818.    Alqahtani AS, Wiley KE, Tashani M, Heywood AE, Willaby HW, BinDhim NF, Booy R, Rashid H. Camel exposure and knowledge about MERS-CoV among Australian Hajj pilgrims in 2014 [letter]. Virologica Sinica 2016;31:89-93. [No abstract available]

819.   Lafond KE, Nair H, Rasooly MH, Valente F, Booy R, Rahman M, Kitsutani P, Yu H, Guzman G, Coulibaly D, Armero J, Jima D, Howie SR, Ampofo W, Mena R, Chadha M, Sampurno OD, Emukule GO, Nurmatov Z, Corwin A, Heraud JM, Noyola DE, Cojocaru R, Nymadawa P, Barakat A, Adedeji A, von Horoch M, Olveda R, Nyatanyi T, Venter M, Mmbaga V, Chittaganpitch M, Nguyen TH, Theo A, Whaley M, Azziz-Baumgartner E, Bresee J, Campbell H, Widdowson MA, Global Respiratory Hospitalizations–Influenza Proportion Positive (GRIPP) Working Group. Global role and burden of influenza in pediatric respiratory hospitalizations, 1982–2012: a systematic analysis. PLoS Medicine 2016;13:e1001977. [Full text]

820.   Hull BP, Dey A, Beard FH, Menzies RI, Brotherton JM, McIntyre PB. Immunisation coverage annual report, 2013. Communicable Diseases Intelligence 2016;40:E146-69. [Full text]

821.   Hendry A. Australian childhood immunisation coverage, 1 July to 30 June cohort, assessed as at 30 September 2015 [quarterly report]. Communicable Diseases Intelligence 2016;40:E177-78. [Full text]

822.   Beard FH, Hull BP, Leask J, Dey A, McIntyre PB. Trends and patterns in vaccination objection, Australia, 2002–2013. Medical Journal of Australia 2016;204:275.e1-6. [Full text]

823.   Dey A, Knox S, Wang H, Beard F, McIntyre P. Summary of national surveillance data on vaccine preventable diseases in Australia, 2008–2011. Communicable Diseases Intelligence 2016;40 Suppl:i-S70. [Full text]

824.   Li-Kim-Moy J, Dastouri F, Rashid H, Khandaker G, Kesson A, McCaskill M, Wood N, Jones C, Zurynski Y, Macartney K, Elliott EJ, Booy R. Utility of early influenza diagnosis through point-of-care testing in children presenting to an emergency department. Journal of Paediatrics and Child Health 2016;52:422-9. [Abstract]

825.   Alfelali M, Khandaker G, Booy R, Rashid H. Mismatching between circulating strains and vaccine strains of influenza: effect on Hajj pilgrims from both hemispheres. Human Vaccines and Immunotherapeutics 2016;12:709-15. [Abstract]

826.   Alfelali M, Alqahtani AS, Barasheed O, Booy R, Rashid H. Mandating influenza vaccine for Hajj pilgrims. The Lancet Infectious Diseases 2016;16:633-4. [Abstract]

827.   Britton PN, Khoury L, Booy R, Wood N, Jones CA. Encephalitis in Australian children: contemporary trends in hospitalisation. Archives of Disease in Childhood 2016;101:51-6. [Abstract]

828.   Zhang S, Sammon PM, King I, Andrade AL, Toscano CM, Araujo SN, Sinha A, Madhi SA, Khandaker G, Yin JK, Booy R, Huda TM, Rahman QS, El Arifeen S, Gentile A, Giglio N, Bhuiyan MU, Sturm-Ramirez K, Gessner BD, Nadjib M, Carosone-Link PJ, Simoes EA, Child JA, Ahmed I, Bhutta ZA, Soofi SB, Khan RJ, Campbell H, Nair H. Cost of management of severe pneumonia in young children: systematic analysis. Journal of Global Health 2016;6:010408. [Full text]

829.   McIntyre PB, Forrest JM. Women in medicine: Margaret Anne Burgess. Medical Journal of Australia 2016;204:389-91. [No abstract available]

830.   Lawrence GL, Wang H, Lahra M, Booy R, McIntyre PB. Meningococcal disease epidemiology in Australia 10 years after implementation of a national conjugate meningococcal C immunization programme. Epidemiology and Infection 2016;144:2382-91. [Abstract]

831.   Safarchi A, Octavia S, Luu LD, Tay CY, Sintchenko V, Wood N, Marshall H, McIntyre P, Lan R. Better colonisation of newly emerged Bordetella pertussis in the co-infection mouse model study. Vaccine 2016;34:3967-71. [Abstract]

832.   Holt PG, Snelling T, White OJ, Sly PD, DeKlerk N, Carapetis J, Biggelaar AV, Wood N, McIntyre P, Gold M. Transiently increased IgE responses in infants and pre-schoolers receiving only acellular diphtheria-pertussis-tetanus (DTaP) vaccines compared to those initially receiving at least one dose of cellular vaccine (DTwP) – Immunological curiosity or canary in the mine? Vaccine 2016;34:4257-62. [Abstract]

833.   Dey A, Wang H, Quinn H, Nicholl S, Macartney K. Surveillance of adverse events following immunisation, NSW, 2014. Sydney: NSW Health; 2016. [Full text]

834.   Gidding HF, Martin NV, Stambos V, Tran T, Dey A, Dowse GK, Kelly HA, Durrheim DN, Lambert SB. Verification of measles elimination in Australia: application of World Health Organization regional guidelines. Journal of Epidemiology and Global Health 2016;6:197-209. [Abstract]

835.   Blyth CC, Macartney KK, Hewagama S, Senenayake S, Friedman ND, Simpson G, Upham J, Kotsimbos T, Kelly P, Cheng AC. Influenza epidemiology, vaccine coverage and vaccine effectiveness in children admitted to sentinel Australian hospitals in 2014: the Influenza Complications Alert Network (FluCAN). Eurosurveillance 2016;21(30):pii=30301. [Full text]

836.   Alqahtani AS, Wiley KE, Mushta SM, Yamazaki K, BinDhim NF, Heywood AE, Booy R, Rashid H. Association between Australian Hajj pilgrims' awareness of MERS-CoV, and their compliance with preventive measures and exposure to camels. Journal of Travel Medicine 2016;23(5):taw046. doi:10.1093/jtm/taw046. [Abstract]

837.   Tashani M, Jayasinghe S, Harboe ZB, Rashid H, Booy R. Potential carrier priming effect in Australian infants after 7-valent pneumococcal conjugate vaccine introduction. World Journal of Clinical Pediatrics 2016;5:311-8. [Full text]

838.   Marshall H, McMillan M, Andrews RM, Macartney K, Edwards K. Vaccines in pregnancy: the dual benefit for pregnant women and infants. Human Vaccines and Immunotherapeutics 2016;12:848-56. [Abstract]

839.   Britton PN, Dale RC, Elliott E, Festa M, Macartney K, Booy R, Jones CA. Pilot surveillance for childhood encephalitis in Australia using the Paediatric Active Enhanced Disease Surveillance (PAEDS) network. Epidemiology and Infection 2016;144:2117-27. [Abstract]

840.   Comeau JL, Chan J, Macartney K. New vaccines on the horizon. Current Pediatrics Reports 2016;4:74-83. [Full text]

841.   Martin N, Durrheim D, Khandaker G, Butler M, Jones C. Using the two-source capture-recapture method to estimate the incidence and case ascertainment of congenital rubella syndrome in Australia, 1993–2013. Western Pacific Surveillance and Response Journal: WPSAR 2016;7(1):34-7. [Full text]

842.   McBride WJ, Abhayaratna WP, Barr I, Booy R, Carapetis J, Carson S, De Looze F, Ellis-Pegler R, Heron L, Karrasch J, Marshall H, McVernon J, Nolan T, Rawlinson W, Reid J, Richmond P, Shakib S, Basser RL, Hartel GF, Lai MH, Rockman S, Greenberg ME. Efficacy of a trivalent influenza vaccine against seasonal strains and against 2009 pandemic H1N1: a randomized, placebo-controlled trial. Vaccine 2016;34:4991-7. [Abstract]

843.   Yezli S, Bin Saeed AA, Assiri AM, Alhakeem RF, Yunus MA, Turkistani AM, Booy R, Alotaibi BM. Prevention of meningococcal disease during the Hajj and Umrah mass gatherings: past and current measures and future prospects. International Journal of Infectious Diseases 2016;47:71-8. [Abstract]

844.   Tashani M, Alfelali M, Azeem MI, Fatema FN, Barasheed O, Alqahtani AS, Tekin H, Rashid H, Booy R. Barriers of vaccinations against serious bacterial infections among Australian Hajj pilgrims. Postgraduate Medicine 2016;128:541-7. [Abstract]

845.   Karki S, Newall AT, MacIntyre CR, Heywood AE, McIntyre P, Banks E, Liu B. Healthcare resource utilisation associated with herpes zoster in a prospective cohort of older Australian adults. PLoS One 2016;11:e0160446. [Full text]

846.   Dixit R, Matthews S, Khandaker G, Walker K, Festa M, Booy R. Pharmacokinetics of oseltamivir in infants under the age of 1 year. Clinical and Translational Medicine 2016;5:37. [Full text]

847.   Sellens E, Norris JM, Dhand NK, Heller J, Hayes L, Gidding HF, Willaby H, Wood N, Bosward KL. Q fever knowledge, attitudes and vaccination status of Australia's veterinary workforce in 2014. PLoS One 2016;11:e0146819. [Full text]

848.   Booy R, Tashani M. Edging ever closer to polio eradication. The Lancet Global Health 2016;4:e592-3. [Abstract]

849.   Tashani M, Rashid H, Mulholland K, Booy R. Carrier priming to improve pneumococcal disease control and reduce the international program’s cost in children [commentary]. Pneumonia 2016;8:16. [Full text]

850.   Pillsbury A, Chiew M, Bag S, Hope K, Norton S, Conaty S, Sheppeard V, McIntyre P. The changing epidemiology of measles in an era of elimination: lessons from health-care-setting transmissions of measles during an outbreak in New South Wales, Australia, 2012. Western Pacific Surveillance and Response Journal: WPSAR 2016;7(4):1-9. [Full text]

851.   Alqahtani AS, BinDhim NF, Tashani M, Willaby HW, Wiley KE, Heywood AE, Booy R, Rashid H. Pilot use of a novel smartphone application to track traveller health behaviour and collect infectious disease data during a mass gathering: Hajj pilgrimage 2014. Journal of Epidemiology and Global Health 2016;6:147-55. [Abstract]

852.   Dey A, Wang H, Quinn HE, Hill R, Macartney K. Surveillance of adverse events following immunisation in Australia annual report, 2014. Communicable Diseases Intelligence 2016;40:E377-90. [Full text]

853.   Zurynski YA, McRae J, Quinn HE, Wood NJ, Macartney K. Paediatric Active Enhanced Disease Surveillance inaugural annual report, 2014. Communicable Diseases Intelligence 2016;40:E391-400. [Full text]

854.   Hendry A. Australian childhood immunisation coverage, 1 January to 31 December cohort, assessed as at 31 March 2016  [quarterly report]. Communicable Diseases Intelligence 2016;40:E444-5. [Full text]

855.   Crawford NW, Hodgson K, Gold M, Buttery J, Wood N. Adverse events following HPV immunization in Australia: establishment of a clinical network. Human Vaccines and Immunotherapeutics 2016;12:2662-5. [Abstract]

856.   Chow MY, Khandaker G, McIntyre P. Global childhood deaths from pertussis: a historical review. Clinical Infectious Diseases 2016;63 Suppl 4:S134-41. [Abstract]

857.   Campbell PT, McVernon J, McIntyre P, Geard N. Influence of population demography and immunization history on the impact of an antenatal pertussis program. Clinical Infectious Diseases 2016;63 Suppl 4:S213-20. [Abstract]

858.   Sobanjo-Ter Meulen A, Duclos P, McIntyre P, Lewis KD, Van Damme P, O'Brien KL, Klugman KP. Assessing the evidence for maternal pertussis immunization: a report from the Bill & Melinda Gates Foundation symposium on pertussis infant disease burden in low- and lower-middle-income countries. Clinical Infectious Diseases 2016;63 Suppl 4:S123-33. [Abstract]

859.   Wattiaux AL, Yin JK, Beard F, Wesselingh S, Cowie B, Ward J, Macartney K. Hepatitis B immunization for indigenous adults, Australia. Bulletin of the World Health Organization 2016;94:826-34A. [Full text]

860.   Saadatian-Elahi M, Plotkin S, Mills KH, Halperin SA, McIntyre PB, Picot V, Louis J, Johnson DR. Pertussis: biology, epidemiology and prevention. Vaccine 2016;34:5819-26. [Abstract]

861.   Karki S, Dyda A, Newall A, Heywood A, MacIntyre CR, McIntyre P, Banks E, Liu B. Comparison of influenza vaccination coverage between immigrant and Australian-born adults. Vaccine 2016;34:6388-95. [Abstract]

862.   Tashani M, Alfelali M, Barasheed O, Alqahtani AS, Heron L, Wong M, Rashid H, Booy R. Effect of Tdap when administered before, with or after the 13-valent pneumococcal conjugate vaccine (coadministered with the quadrivalent meningococcal conjugate vaccine) in adults: a randomised controlled trial. Vaccine 2016;34:5929-37. [Abstract]

863.   Shevlin M, Coen PG, Borg J, Booy R, Viner RM, Christie D. Development of a health related quality of life measure for adolescents and young adults following invasive meningococcal disease. Applied Research in Quality of Life 2016;11:971-82. [Full text]

864.   Hayles EH, Cooper SC, Sinn J, Wood N, Leask J, Skinner SR. Pertussis vaccination coverage among Australian women prior to childbirth in the cocooning era: a two-hospital, cross-sectional survey, 2010 to 2013. Australian and New Zealand Journal of Obstetrics and Gynaecology 2016;56:185-91. [Abstract]

865.   Alqahtani AS, Wiley KE, Tashani M, Willaby HW, Heywood AE, BinDhim NF, Booy R, Rashid H. Exploring barriers and facilitators of preventive measures against infectious diseases among Australian Hajj pilgrims: cross sectional studies before and after Hajj. International Journal of Infectious Diseases 2016;47:53-9. [Abstract]

866.   Barasheed O, Alfelali M, Mushta S, Bokhary H, Alshehri J, Attar AA, Booy R, Rashid H. Uptake and effectiveness of facemask against respiratory infections at mass gatherings: a systematic review. International Journal of Infectious Diseases 2016;47:105-11. [Abstract]

867.   Li-Kim-Moy J, Yin JK, Patel C, Beard FH, Chiu C, Macartney KK, McIntyre PB. Australian vaccine preventable disease epidemiological review series: Influenza 2006 to 2015. Communicable Diseases Intelligence 2016;40:E482-95. [Full text]

868.   Cheng AC, Holmes M, Dwyer DE, Irving LB, Korman TM, Senenayake S, Macartney KK, Blyth CC, Brown S, Waterer GW, Hewer R, Friedman ND, Wark PA, Simpson G, Upham J, Bowler SD, Lessing A, Kotsimbos T, Kelly PM. Influenza epidemiology in patients admitted to sentinel Australian hospitals in 2015: the Influenza Complications Alert Network. Communicable Diseases Intelligence 2016;40:E521-6. [Full text]

869.   Martin NV, Ong KS, Howden BP, Lahra MM, Lambert SB, Beard FH, Dowse GK, Saul N. Rise in invasive serogroup W meningococcal disease in Australia, 2013–2015. Communicable Diseases Intelligence 2016;40:E454-9. [Full text]

870.   Corben P, Leask J. To close the childhood immunization gap, we need a richer understanding of parents' decision-making. Human Vaccines and Immunotherapeutics 2016;12:3168-76. [Abstract]

871.   Hendry AJ, Dey A, Beard FH, Khandaker G, Hill R, Macartney KK. Adverse events following immunisation with bacille Calmette-Guérin vaccination: baseline data to inform monitoring in Australia following introduction of new unregistered BCG vaccine. Communicable Diseases Intelligence 2016;40:E470-4. [Full text]

872.   Hendry AJ. Australian childhood immunisation coverage, 1 April 2015 to 31 March 2016 cohort, assessed as at 30 June 2016 [quarterly report]. Communicable Diseases Intelligence 2016;40:E552-3. [Full text]

873.   DeSilva M, Munoz FM, Mcmillan M, Kawai AT, Marshall H, Macartney KK, Joshi J, Oneko M, Elliott Rose A, Dolk H, Trotta F, Spiegel H, Tomczyk S, Shrestha A, Kochhar S, Kharbanda EO, The Brighton Collaboration Congenital Anomalies Working Group. Congenital anomalies: case definition and guidelines for data collection, analysis, and presentation of immunization safety data. Vaccine 2016;34:6015-26. [Abstract]

874.   Snelling T, McIntyre P. Modeling the effects of priming with the whole-cell Bordetella pertussis vaccine [letter]. JAMA Pediatrics 2016;170:1228-9. [No abstract available]

875.   Khandaker G, Jung J, Britton PN, King C, Yin JK, Jones CA. Long-term outcomes of infective encephalitis in children: a systematic review and meta-analysis. Developmental Medicine and Child Neurology 2016;58:1108-15. [Abstract]

876.   Newcombe PJ, Kaur R, Wood N, Seale H, Palasanthiran P, Snelling TL. Paediatrician beliefs and practices around influenza vaccination. Journal of Paediatrics and Child Health 2016; November: [Epub ahead of print] doi:10.1111/jpc.13406. [Abstract]



Last updated 15 May 2017